Inhibition of the PPP and silencing of two PPP enzymes, glucose-6-phosphate dehydrogenase (G6PD) and phosphoglycerate dehydrogenase (PGD), hinders erastin-induced ferroptosis in human lung cancer cells (3). Here, G6PD is linked to lung cancer.